ISS STAGE II PLASMA CELL MYELOMA

Clinical trials for ISS STAGE II PLASMA CELL MYELOMA explained in plain language.

Never miss a new study

Get alerted when new ISS STAGE II PLASMA CELL MYELOMA trials appear

Sign up with your email to follow new studies for ISS STAGE II PLASMA CELL MYELOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Custom immune cells fight blood cancers after transplant

Disease control Recruiting now

This study tests a personalized immune cell therapy for patients with blood cancers like leukemia, lymphoma, and myeloma. After receiving chemotherapy and a cord blood transplant, patients get infusions of natural killer (NK) cells—immune cells that may kill remaining cancer cell…

Matched conditions: ISS STAGE II PLASMA CELL MYELOMA

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 23, 2026 15:18 UTC

ISS STAGE II PLASMA CELL MYELOMA

Get alerted when new ISS STAGE II PLASMA CELL MYELOMA trials appear

Custom immune cells fight blood cancers after transplant